In our study, if we simply compared CRSwNP patients (which includes both ECRS and non-ECRS patients, n = 20) and controls, there was no significant difference in GATA3 expression between them (p = 0.11). The gene discussed is GATA3; the disease is chronic rhinosinusitis with nasal polyps.